Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab Combined With Chemotherapy for CD20+ Adult ALL
NCT01358253Phase 4Completed
- Sponsor
- Ruijin Hospital
- Start
- Dec 2010
- Primary completion
- Dec 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of rituximab in acute lymphoblastic leukemia (ALL), sponsored by Ruijin Hospital. Started Dec 2010; status: completed.
02
Drugs
rituximab
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT01358253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01358253.